Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0476089 (endometrial cancer)
 11,379 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A 60-year-old woman with recurrent stage II endometrial cancer (clear cell adenocarcinoma) was treated with combination chemotherapy containing cisplatin (CDDP). She had undergone abdominal radical hysterectomy (Okabayashi operation) and pelvic lymph node dissections. Endometrial cancerous tissue infiltrated the cervix and lymph nodes. Six months after the operation, the patient had ascites and dyspnea. She was given 25 mg CDDP intra-abdominally and combination chemotherapy containing CDDP (CAP: CDDP 100 mg, ADR 30 mg, CAP 500 mg) three times intravenously. After an administration of CDDP and combination chemotherapy, the amount of ascites and the serum level of CA 125 decreased remarkably. Although the combination chemotherapy containing CDDP for gynecological malignancy has not been sufficiently evaluated as for ovarian carcinomas, the therapy deserves further evaluation in patients with recurrent of endometrial cancer.
 ...
PMID:[A case of recurrent endometrial cancer (clear cell adenocarcinoma) remarkably responsive to combination chemotherapy containing cisplatin]. 273 95

Based on 27 rare forms of carcinoma of the endometrium (adenoacanthomas, clear cell adenocarcinomas, mulleroblastomas, leiomyosarcomas), the authors discuss their observations and compare their findings with literature data. The only forms with a more favorable prognosis than cancer of the endometrium is pure adenoacanthoma. Delays in diagnosis remain all too frequent. Post-surgery treatment including chemotherapy appears preferable to surgery alone for these severe lesions which result more often in local recurrences than in pulmonary metastases. New chemotherapy associations (ADR-DTIC) have given results which justify their use, while radiotherapy and curietherapy reduce the number of recurrences, except for leiomyosarcomas.
 ...
PMID:[27 cases of rare forms of cancer of the corpus uteri]. 653 26

A herbal complex consisting of Hoelen, Angelicae radix, Scutellariae radix and Glycyrrhizae radix suppressed cell viability and telomerase activity in hormone-refractory and chemo-resistant cancer cell lines, namely poorly differentiated uterine endometrial cancer cell line AN3 CA, adriamycin-resistant breast cancer cell line MCF7/ADR and cisplatin-resistant ovarian cancer cell line A2780. Furthermore, the herbal complex suppressed the expression of the full length of human telomerase reverse transcriptase (hTERT), which is related to telomerase activity. This indicates that the herbal complex can suppress the tumor growth of chemoendocrine resistant cancers, at least in part via suppression of telomerase activity associated with down-regulated hTERT.
 ...
PMID:Herbal complex suppresses telomerase activity in chemo-endocrine resistant cancer cell lines. 1176 37